Christoph Abels (C Abels)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Venues

Experimental dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

The British journal of dermatology

Postgraduate medicine

Dr. August Wolff GmbH & Co. KG Arzneimittel

Ludwig-Maximilians-Universität München (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dr. August Wolff GmbH & Co. KG Arzneimittel Jul 01 2004

Germany

Medical Director

Baxter Deutschland GmbH Feb 01 2003 - Jun 30 2004

Germany

Medical Advisor :: Baxter Bioscience

Education History

Ludwig-Maximilians-Universität München Mar 01 1993 - Sep 30 1995

Germany

PHD :: Institute for Surgical Research

Publications

Kinga Fanni Tóth, Dorottya Ádám, József Arany, Yesid A Ramirez, Tamás Bíró, Jennifer I Drake, Alison O'Mahony, Attila Gábor Szöllősi, Szilard Poliska, Ana Kilić, Michael Soeberdt, Christoph Abels, Attila Oláh
Fluoxetine exerts anti-inflammatory effects on human epidermal keratinocytes and suppresses their endothelin release. Experimental dermatology 33 (1) (2024)
Rolf-Markus Szeimies, Christoph Abels, Ana Kilic, Hubert Reich, Birgit Berger, Erik Schulze Zur Wiesche, Katharina Schramm, Leonie Litzka, Susanne Heimstaedt-Muskett, Clarissa Masur
Long-term efficacy and safety of 1% glycopyrronium bromide cream in patients with severe primary axillary hyperhidrosis: Results from a Phase 3b trial. Journal of the European Academy of Dermatology and Venereology : JEADV 37 (4) (2023)
Rolf-Markus Szeimies, Christoph Abels, Ana Kilic, Hubert Reich, Birgit Berger, Erik Schulze Zur Wiesche, Katharina Schramm, Leonie Litzka, Susanne Heimstaedt-Muskett, Clarissa Masur
Long-term efficacy and safety of 1% glycopyrronium bromide cream in patients with severe primary axillary hyperhidrosis: Results from a Phase 3b trial. Journal of the European Academy of Dermatology and Venereology : JEADV 37 (4) (2023)
Claudia B Bittner, Hubert Steindl, Dimitri Abramov-Sommariva, Michael Plach, Christoph Abels, Claus Bachert
Efficacy and effectiveness of the herbal medicinal product BNO 1016 in the management of acute rhinosinusitis in the context of antibiotic stewardship. Postgraduate medicine (2023)
R-M Szeimies, Christoph Abels, A Kilic, H Reich, B Berger, E Schulze Zur Wiesche, K Schramm, Leonie Litzka, S Heimstaedt-Muskett, Clarissa Masur
Long-term efficacy and safety of 1% glycopyrronium bromide cream in patients with severe primary axillary hyperhidrosis: results from a Phase 3b trial. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Rolf-Markus Szeimies, Christoph Abels, Ana Kilic, Hubert Reich, Birgit Berger, Erik Schulze Zur Wiesche, Katharina Schramm, Leonie Litzka, Susanne Heimstaedt-Muskett, Clarissa Masur
Long-term efficacy and safety of 1% glycopyrronium bromide cream in patients with severe primary axillary hyperhidrosis: Results from a Phase 3b trial. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Claudia B Bittner, Michael Plach, Hubert Steindl, Dimitri Abramov-Sommariva, Christoph Abels, Karel Kostev
Prevalence of Antibiotic Prescription in Patients with Acute Rhinosinusitis Treated by General Practitioners and Otolaryngologists in Germany-A Retrospective Cohort Study. Antibiotics (Basel, Switzerland) 11 (11) (2022)
Christoph Abels, Michael Soeberdt, A Kilic, H Reich, U Knie, C Jourdan, K Schramm, S Heimstaedt-Muskett, Clarissa Masur, Rolf-Markus Szeimies
A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial. The British journal of dermatology 185 (2) (2021)
Rosanna Marsella, Kim Ahrens, Rachel Wilkes, Michael Soeberdt, Christoph Abels
Topical κ-opioid receptor agonist asimadoline improves dermatitis in a canine model of atopic dermatitis. Experimental dermatology (2021)
Ehrhardt Proksch, Michael Soeberdt, Claudia Neumann, Ana Kilic, Christoph Abels
Modulators of the endocannabinoid system influence skin barrier repair, epidermal proliferation, differentiation and inflammation in a mouse model. Experimental dermatology 28 (9) (2020)
Jeremy Chéret, Jennifer Gherardini, Michael Soeberdt, Jennifer E Hundt, Christoph Abels, Marta Bertolini, Ralf Paus
Non-neuronal kappa-opioid receptor activation enhances epidermal keratinocyte proliferation, and modulates mast cell functions in human skin ex vivo. The Journal of dermatology 47 (8) (2020)
Michaela Gabes, C Jourdan, K Schramm, C Masur, Christoph Abels, P Kamudoni, S Salek, Christian J Apfelbacher
Hyperhidrosis Quality of Life Index (HidroQoL©): further validation and clinical application in patients with axillary hyperhidrosis using data from a phase III randomized controlled trial. The British journal of dermatology 184 (3) (2020)
Michael Soeberdt, Ana Kilic, Christoph Abels
Current and emerging treatments targeting the neuroendocrine system for disorders of the skin and its appendages. Experimental dermatology 29 (9) (2020)
C Masur, Michael Soeberdt, A Kilic, U Knie, Christoph Abels
Safety and efficacy of topical formulations containing 0·5, 1 and 2% glycopyrronium bromide in patients with primary axillary hyperhidrosis: a randomized, double-blind, placebo-controlled study. The British journal of dermatology 182 (1) (2019)
Christoph Abels, Michael Soeberdt
Can we teach old drugs new tricks?-Repurposing of neuropharmacological drugs for inflammatory skin diseases. Experimental dermatology 28 (9) (2019)

Christoph Abels.css-eqlu8i{font-size:small;padding-left:4px;} (C Abels)

Publication Activity (10 Years)

Top Topics

Top Venues

Christoph Abels (C Abels)